Floatz logo

Montanide Isa-51

Pancreatic Adenocarcinoma

University of ChicagoPhase 1/2Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
73/ 100

Competitive context

77 Active assets in the Pancreatic Adenocarcinoma cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Jonsson Comprehensive Cancer Center
Phase 4BBB
Irinotecan
Jonsson Comprehensive Cancer Center
Phase 3BB
Eloxatin
Jonsson Comprehensive Cancer Center
Phase 4BB
Calcium folinate pentahydrate
Jonsson Comprehensive Cancer Center
Phase 4BB
Capecitabine
Zhejiang University
Phase 4BB

View all 50 →

Same molecule, other indications

Montanide Isa-51 is also rated in:

MelanomaDormant
BB
Indicative ·
64 / 100
View asset →
Advanced Renal Cell CancerDormant
BB
Indicative ·
64 / 100
View asset →
Stage IV MelanomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →